CLASS II Drug recall · Reported 9 Jul 2014 · FDA Enforcement Report

Brevibloc Premixed Injection, Esmolol Hydrochloride recalled

Baxter Healthcare is recalling Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/ (10, distributed nationwide in the US. The recall was initiated on 16 Jun 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: C926923, Exp 01/16
NDC10019-055, 10019-115, 10019-075
Quantity recalled20,810 containers

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1413-2014
FDA event ID
68577
Recalling firm
Baxter Healthcare, Deerfield, IL
Manufacturer
Baxter Healthcare Company
Classification
Class II
Status
Terminated
Recall initiated
16 Jun 2014
FDA classified
1 Jul 2014
Reported
9 Jul 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

16 Jun 2014Recall initiated by company
1 Jul 2014Classified by FDA+15 days
9 Jul 2014Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.

Product as listed by the FDA

Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL (10 mg/mL), 250 mL Single Use IntraVia container, packaged in 10 x 250 mL Single Use IntraVia containers per carton, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1415, NDC 10019-055-61.

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.

Which lots are affected?

Lot #: C926923, Exp 01/16

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Baxter Healthcare

All 564

Other Esmolol recalls

All 5